This is a preview of subscription content, log in to check access.
Buy single article
Instant access to the full article PDF.
Price includes VAT for USA
Subscribe to journal
Immediate online access to all issues from 2019. Subscription will auto renew annually.
This is the net price. Taxes to be calculated in checkout.
Rizos T, Güntner J, Jenetzky E, Marquardt L, Reichardt C, Becker R, Reinhardt R, Hepp T, Kirchhof P, Aleynichenko E, Ringleb P, Hacke W, Veltkamp R (2012) Continuous stroke unit electrocardiographic monitoring versus 24 h Holter electrocardiography for detection of paroxysmal atrial fibrillation after stroke. Stroke 43:2689–2694
Benbir G, Uluduz D, Ince B, Bozluolcay M (2007) Atherothrombotic ischemic stroke in patients with atrial fibrillation. Clin Neurol Neurosurg 109:485–490
Hart RG, Pearce LA, Miller VT, Anderson DC, Rothrock JF, Albers GW, Nasco E (2000) Cardioembolic versus non-cardioembolic strokes in atrial fibrillation: frequency and effect of antithrombotic agents in the stroke prevention in atrial fibrillation studies. Cerebrovasc Dis 10:39–43
Kim YD, Cha MJ, Kim J, Lee DH, Lee HS, Nam CM, Nam HS, Heo JH (2011) Increases in cerebral atherosclerosis according to CHADS2 scores in patients with stroke with non-valvular atrial fibrillation. Stroke 42:930–934
Chimowitz MI, Lynn MJ, Howlett-Smith H, Stern BJ, Hertzberg VS, Frankel MR, Levine SR, Chaturvedi S, Kasner SE, Benesch CG, Sila CA, Jovin TG, Romano JG (2005) Comparison of warfarin and aspirin for symptomatic intracranial arterial stenosis. N Engl J Med 352:1305–1316
Chimowitz MI, Lynn MJ, Derdeyn CP et al (2011) Stenting versus aggressive medical therapy for intracranial arterial stenosis. N Engl J Med 365:993–1003
Hart RG, Pearce LA, Aguilar MI (2007) Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation. Ann Intern Med 146:857–867
Connolly SJ, Ezekowitz MD, Yusuf S et al (2009) Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med 361:1139–1151
Granger CB, Alexander JH, McMurray JJ et al (2011) Apixaban versus Warfarin in patients with atrial fibrillation. N Engl J Med 365:981–992
Patel MR, Mahaffey KW, Garg J et al (2011) Rivaroxaban versus warfarin in non-valvular atrial fibrillation. N Engl J Med 365:883–891
Mega JL, Braunwald E, Wiviott SD et al (2012) Rivaroxaban in patients with a recent acute coronary syndrome. N Engl J Med 366:9–19
Flaker GC, Eikelboom JW, Shestakovska O et al (2012) Bleeding during treatment with aspirin versus apixaban in patients with atrial fibrillation unsuitable for warfarin. The apixaban versus acetylsalicylic acid to prevent stroke in atrial fibrillation patients who have failed or are unsuitable for vitamin K antagonist treatment. Stroke 43:3291–3297
Alexander JH, Lopes RD, James S et al (2011) Apixaban with antiplatelet therapy after acute coronary syndrome. N Engl J Med 365:699–708
Azoulay L, Dell’aniello S, Simon T, Renoux C, Suissa S (2013) The concurrent use of antithrombotic therapies and the risk of bleeding in patients with atrial fibrillation. Thromb Haemost 109: dx.doi.org/10.1160/TH12-08-0542
Conflict of interest
The authors declare that they have no conflict of interest.
About this article
Cite this article
Stöllberger, C., Bastovansky, A. & Finsterer, J. Is there a role for new oral anticoagulants as primary and secondary stroke prevention in atrial fibrillation and intracranial stenosis?. J Thromb Thrombolysis 36, 492–494 (2013). https://doi.org/10.1007/s11239-013-0884-1
- Atrial Fibrillation
- Posterior Cerebral Artery